Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Pain 10Neoplasms 9Marijuana Abuse 5Cancer Pain 5Glioblastoma 2Squamous Cell Carcinoma of Head and Neck 1Signs and Symptoms 1Recurrence 1Parasomnias 1Pancreatic Neoplasms 1Neuralgia 1Nausea 1Multiple Sclerosis 1Mouth Neoplasms 1Marijuana Use 1Diabetes Mellitus 1Chronic Pain 1Cachexia 1Breast Neoplasms 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1Advanced Malignant Solid Tumor 1Advanced Cancer 11- Cancer Patients During Chemotherapy Treatment 1

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × nabiximols × Clear all
NCT05969314 2025-04-11

To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

Tata Memorial Hospital

Phase 1 Active not recruiting
12 enrolled
BreastHead & Neck

Breast Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡